Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
meningococcal infections
MeSH D008589 - meningococcal infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016870:
Neisseriaceae infections
29 Companies
2 Drugs
$
Success rate
D008589:
Â
Meningococcal infections
46 Companies
7 Drugs
$
Success rate
D008585:
Meningococcal meningitis
35 Companies
9 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
100
%
1/1
Phase 3
83
%
5/6
Approved:
4
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Journey Medical
Minocycline
GSK
Ampicillin
,
Benzocaine
,
Antithrombin iii
,
Ademetionine
,
Sodium chloride
,
Edetic acid
,
Nimenrix
,
Synflorix
,
Twinrix
,
Fendrix
,
Fluzone
,
Prevenar13
,
Prevnar13
,
Menactra
,
Pcv13
,
Pneumovax
,
Articular
,
Ipv
,
Flumist
,
Pcv
,
Flucelvax
,
Prevenar
Bausch Health Companies
Minocycline
Pfizer
Penicillin g benzathine
,
Penicillin g procaine
,
Ampicillin
,
Penicillin g
,
Sulbactam
,
Antithrombin iii
,
Ademetionine
,
Sodium chloride
,
Bevifimod
,
Nimenrix
,
Prevenar13
,
Menactra
,
Pcv13
,
Pneumovax
,
Articular
,
Prevenar
Dr Reddys Laboratories
Minocycline
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use